In some series, over 50% of patients with MMNSTs have evidence of Carney complex, an autosomal dominant, occasionally familial multiple neoplasia syndrome (27)
For organizations with scalable clinical oversight infrastructure, this could unlock: Program expansion Standardized protocols Increased patient demand Greater legitimacy in the market However, readiness will determine who capitalizes on the opportunity
Not every risk applies equally to every medicine, but these are common monitoring themes in the incretin space
Semaglutide targets GLP-1 receptors, while tirzepatide is a dual GIP/GLP-1 receptor agonist
Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation
Any weight-related changes people report are more likely tied to improved recovery and training consistency rather than a direct metabolic effect